Prognostic variables in male breast cancer

American Surgeon

Volumn 66, Issue 5, 2000, Pages 502-511

  Clark, John L ^b   Nguyen, Phuong L ^c   Jaszcz, Waclaw B ^c   Jatoi, Aminah ^a   Niehans, Gloria A ^c  

^a MAYO CLINIC   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE S PHASE; CLINICAL ARTICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MALE; PLOIDY; PROGNOSIS; PROTEIN EXPRESSION;

ADULT; AGED; BREAST NEOPLASMS, MALE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0034024111     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (102)

1. Bavafa S, Reyes CV, Choudhury AM. Male breast carcinoma: An updated experience at a Veterans Administration hospital and review of the literature. J Surg Oncol 1983;24;41-5.
2. Landis SH, Murray T, Bolden S, Wingo PA. Cancer Statistics, 1999. CA Cancer J Clin 1999;49:8-31.
3. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term followup. Histopathology 1991;19:403-10.
4. Hedley D, Friedlander M, Taylor I, et al. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983;31: 1333-5.
5. Fleming ID, Cooper JS, Henson DE, et al, eds. American Joint Committee on Cancer Staging Manual, 5th Ed. Philadelphia: JB Lippincott, 1997.
6. Donegan EL, Perez-Mesa CM. Carcinoma of the male breast: A 30-year review of 28 cases. Arch Surg 1973;106:272-9.
7. Cutuli B. Lacroze M, Dilhuydy JM, et al. Male breast cancer: Results of the treatments and prognostic factors in 397 cases. Eur J Cancer 1995;31A:1960-1964.
8. Ihekwaba FN. Breast cancer in men in black Africa: A report of 73 cases. J R Coll Surg Edinb 1994;39:344-7.
9. Lefor AT, Numann PJ. Carcinoma of the breast in men. NY State J Med 1988;88:293-6.
10. Crocetti E, Buiatti E. Male breast cancer: Incidence, mortality and survival rates from an Italian population-based series. Eur J Cancer 1994;30A:1732-1733.
11. Stierer M, Rosen H, Weitensfelder W, et al. Male breast cancer: Austrian experience. World J Surg 1995;19:687-93.
12. Joshi MG, Lee AKC, Loda M, et al. Male breast carcinoma: An evaluation of prognostic factors contributing to a poorer outcome. Cancer 1996;77:490-8.
13. Salvadori B, Saccozzi R, Manzari A, et al. Prognosis of breast cancer in males: An analysis of 170 cases. Eur J Cancer 1994;30A:930-5.
14. Wainwright J. Carcinoma of the male breast: Clinical and pathological study. Arch Surg 1927;14:836-59.
15. Crichlow RW. Carcinoma of the male breast. Surg Gynecol Obstet 1972;134:1011-9.
16. Heller KS, Rosen PP, Schottenfeld D, et al. Male breast cancer: A clinicopathologic study of 97 cases. Ann Surg 1978; 188:60-5.
17. Norris HJ, Taylor HB. Carcinoma of the male breast. Cancer 1969;23:1428-35.
18. van Geel AN, van Slooten EA, Mavrunac M, Hart AAM. A retrospective study of male breast cancer in Holland. Br J Surg 1985;72:724-7.
19. Vercoutere AL, O'Connell TX. Carcinoma of the male breast. Arch Surg 1984;119:1301-4.
20. Guinee VF, Olsson H, Moller T, Shallenberger RC, et al. The prognosis of breast cancer in males. Cancer 1993;71:154-61.
21. Willsher PC, Leach IH, Ellis IO, et al. A comparison outcome of male breast cancer with female breast cancer. Am J Surg 1997;173:185-8.
22. Erlichman C, Murphy KC, Elhakim T. Male breast cancer: A 13-year review of 89 patients. J Clin Oncol 1984;2;903-9.
23. Hultborn R, Friberg S, Hultborn KA. Male breast carcinoma: A study of the total material reported to the Swedish Cancer Registry 1958-1967 with respect to clinical and histopathologic parameters. Acta Oncologica 1987;26:241-56.
24. Rudan I, Rudan N. Strnad M. Differences between male and female breast cancer. I. Epidemiological features. Acta Med Croatica 1995;49:117-20.
25. Sasco AJ, Fontaniere B. A population-based series of 10 males breast cancer cases. Eur J Cancer 1991;27:1713.
26. Ajayi DOS, Osegbe DN, Ademiluyi SA. Carcinoma of the male breast in West Africans and a review of world literature. Cancer 1982;50:1664-7.
27. Williams WL, Powers M, Wagman LD. Cancer of the male breast: A review. J Natl Med Assoc 1996:88:439-43.
28. Shukla NK, Seenu V, Goel AK, et al. Male breast cancer: A retrospective study from a regional cancer center in northern India. J Surg Oncol 1996;61:143-8.
29. Gupta S, Pant GC, Gupta S. Male breast cancer. J Surg Oncol 1981;16:149-57.
30. Sasco AJ, Lowenfels AB, Pasker-DeJong P. Review article: Epidemiology of male breast cancer: A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer 1993;53:538-49.
31. Casagrande JT, Hanisch R, Pike MC, et al. A case-control study of male breast cancer. Cancer Res 1988;48:1326-30.
32. Misra SP, Misra V, Dwivedi M. Cancer of the breast in a male cirrhotic: Is there an association between the two? Am J Gastroenterol 1996;91:380-2.
33. El-Gazayerli MM, Abdel-Aziz AS. On bilharziasis and male breast cancer in Egypt: A preliminary report and review of the literature. Br J Cancer 1963;17:566-71.
34. Halsted WS. The results of radical operations for cure of cancer of the breast performed at the Johns Hopkins Hospital. Ann Surg 1894;20:497.
35. Nemoto T, Vana J, Bedwani RN, et al. Management and survival of female breast cancer: Results of a national survey by American College of Surgeons. Cancer 1980;45:2917-24.
36. Fisher B, Anderson S, Redmond CK, et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995; 333:1456-61.
37. Digenis AG, Ross CB, Morrison JG, et al. Carcinoma of the male breast: A review of 41 cases. South Med J 1990;83:1162-7.
38. Ouriel K, Lotze MT, Hinshaw JR. Prognostic factors of carcinoma of the male breast. Surg Gynecol Obstet 1984;159: 373-6.
39. Winchester DJ. Male breast cancer. Semin Surg Oncol 1996;12:364-9.
40. Donegan WL. Cancer of the male breast. In: Donegan WL, Spratt JS. Cancer of the Breast, 4th Ed. Philadelphia: WB Saunders Co, 1995, pp 765-77.
41. Ribiero G. Male breast carcinoma: A review of 301 cases from the Christie Hospital & Holt Radium Institute, Manchester. Br J Cancer 1985;51:115-9.
42. Hodson GR, Urdaneta LF, Al-Jurf AS, Jochimsen PR. Male breast carcinoma. Am Surg 1985;51:47-9.
43. Borgen PI, Wong GY, Vlamis V, et al. Current management of male breast cancer: A review of 104 cases. Ann Surg 1992;215: 451-9.
44. Nance KV, Reddick RL. In situ and infiltrating lobular carcinoma of the male breast. Hum Pathol 1989;20:1220-2.
45. Sanchez AG, Villanueva AG, Redondo C. Lobular carcinoma of the breast in a patient with Klinefelter's syndrome: A case with bilateral, histologically different breast tumors. Cancer 1986; 57:1181-3.
46. Donegan WL, Redlich PN. Breast cancer in men. Surg Clin North Am 1996;76:343-63.
47. Willsher PC, Leach IH, Ellis IO. et al. Male breast cancer: Pathological and immunohistochemical features. Anticancer Res 1997;17:2335-8.
48. Gough DB, Donohue JH, Evans MM, et al. A 50-year experience of male breast cancer: Is outcome changing? Surg Oncol 1993;2:325-33.
49. Visfelt J, Scheike O. Male breast cancer. I. Histologic typing and grading of 187 Danish cases. Cancer 1973;32:985-90.
50. McLachlan S, Erlichman C, Liu F-F, et al. Male breast cancer: An 11 year review of 66 patients. Breast Cancer Res Treat 1996;40:225-30.
51. Spence RAJ, Mackenzie G, Anderson JR, et al. Long-term survival following cancer of the male breast in Northern Ireland. Cancer 1985;55:648-52.
52. Hatschek T, Wingren S, Carstensen J, Hultborn R. DNA content and S-phase fraction in male breast carcinomas. Acta Oncol 1994;33:609-13.
53. Yap HY, Tashima CK, Blumenschein GR, Eckles NE. Male breast cancer: A natural history study. Cancer 1979;44:748-54.
54. Cunha F, Andre S, Soares J. Morphology of male breast carcinoma in the evaluation of prognosis. Pathol Res Pract 1990; 186:745-50.
55. Schuchardt U, Seegenschmiedt H, Kirschner MJ, et al. Adjuvant radiotherapy or breast carcinoma in men: A 20-year clinical experience. Am J Clin Oncol 1996;19:330-6.
56. Adami H-O, Hakulinen T, Ewertz M, et al. The survival pattern in male breast cancer: An analysis of 1429 patients from the Nordic countries. Cancer 1989;64:1177-82.
57. Engin K, Unsal M. Cancer of the male breast: The Turkish experience. J Surg Oncol 1993;53:128-32.
58. Scheike O, Male breast cancer: Factors influencing prognosis. Br J Surg 1974;30:261-70.
59. Sandler B, Carman C, Perry RR. Cancer of the male breast. Am Surg 1994;60:816-20.
60. Kinne DW. Management of male breast cancer. Oncology 1991;5:45-8.
61. Patel HZ, Buzdar AU, Hortobagyi GN. Role of adjuvant chemotherapy in male breast cancer. Cancer 1989;64:1583-5.
62. Bagley CS, Wesle MN, Young RC, Lippman ME. Adjuvant chemotherapy in males with cancer of the breast. Am J Clin Oncol 1987;10:55-60.
63. Izquierdo MA, Alonso C, de Andres L, Ojeda B. Male breast cancer: Report of a series of 50 cases. Acta Oncol 1994;33: 767-71.
64. Ribiero G, Swindell R. Adjuvant tamoxifen for male breast cancer (MBC). Br J Cancer 1992;65:252-4.
65. Moredo Anelli TF, Anelli A, et al. Tamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patients. Cancer 1994;74:74-7.
66. Rosen PR, Menendez-Botet CJ, Nisselbaum JS. et al. Estrogen receptor protein in lesions of the male breast. Cancer 1976; 37:1866-8.
67. Leclercq G, Verhest A, Deboel MC, et al. Oestrogen receptors in male breast cancer. Biomedicine 1976;25:327-30.
68. Gupta N, Cohen JL, Rosenbaum C, Raam S. Estrogen receptors in male breast cancer. Cancer 1980;46:1781-4.
69. Everson RB, Lippman ME, Thompson EB, et al. Clinical correlations of steroid receptors and male breast cancer. Cancer Res 1980;40:991-7.
70. Friedman MA, Hoffman PG, Dandolos EM, et al. Estrogen receptors in male breast cancer: Clinical and pathologic correlations. Cancer 1981;47:134-7.
71. Pich A, Margaria E, Chiusa L. Proliferative activity is a significant prognostic factor in male breast carcinoma. Am J Pathol 1994;145:481-9.
72. Rogers S, Day CA, Fox SB. Expression of cathespin D and estrogen receptor in male breast carcinoma. Hum Pathol 1993;24: 148-51.
73. Pegoraro RJ, Nirmul D, Joubert SM. Cytoplasmic and nuclear estrogen and progesterone receptors in male breast cancer. Cancer Res 1982;42:4812-4.
74. Sasano H, Kimura M, Shizawa S, et al. Aromatase and steroid receptors in gynecomastia and male breast carcinoma: An immunohistochemical study. J Clin Endocrinol Metab 1996;81: 3063-7.
75. Tan RH, Sng ITY. Male breast cancer: A retrospective study with immunohistochemical analysis of hormone receptor expression. Pathology 1997;29:2-6.
76. Ruff SJ, Bauer JE, Keenan EJ, et al. Hormone receptors in male breast carcinoma. J Surg Ortcol 1981;18:55-9.
77. Donegan WL. Prognostic factors: Stage and receptor status in breast cancer. Cancer 1992;70:1755-64.
78. Kardas I, Seitz G, Limon J, et al. Retrospective analysis of prognostic significance of the estrogen-inducible pS2 gene in male breast carcinoma. Cancer 1993;72:1652-6.
79. Morimoto T, Komaki K, Yamakawa T, et al. Cancer of the male breast. J Surg Oncol 1990;44:180-4.
80. Kallioniemi O-P, Blanco G, Alavaikko M, et al. Tumour DNA ploidy as an independent prognostic factor in breast cancer. Br J Cancer 1987;56:637-42.
81. Yuan J, Hennessy C, Corbett IP, et al. Node negative breast cancer: The prognostic value of DNA ploidy for long-term survival. Br J Surg 1991;78:844-8.
82. Hedley DW, Rugg CA, Gelber RD. Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer. Cancer Res 1987;47:4729-35.
83. Batsakis JG, Sneige N, El-Naggar AK. Flow cytometric (DNA content and S-phase fraction) analysis of breast cancer. Cancer 1993;71:2151-3.
84. Merkel DE, Winchester DJ, Goldschmidt RA, et al. DNA flow cytometry and pathologic grading as prognostic guides in axillary lymph node-negative breast cancer. Cancer 1993;72: 1926-32.
85. McGuire WL. Clark GM. Prognostic factors and treatment decisions in axillary-node-negative breast cancer. N Engl J Med 1992;326:1756-61.
86. Pich A, Margaria E, Chiusa L, et al. DNA ploidy and p53 expression correlate with survival and cell proliferative activity in male breast carcinoma. Hum Pathol 1996;27:676-82.
87. Gattuso P, Reddy VB, Green L, et al. Prognostic significance of DNA ploidy in male breast carcinoma: A retrospective analysis of 32 cases. Cancer 1992;70:777-80.
88. Jonasson JG, Agnarsson BA, Thorlacius S, et al. Male breast cancer in Iceland. Int J Cancer 1996;65:446-9.
89. Vogelstein B. A deadly inheritance. Nature 1990;348: 681-2.
90. Thor AD, Moore DH H, Edgerton SM, et al. Accumulation of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancers. J Natl Cancer Inst 1992;84:845-55.
91. Nayak BK, Baral RN. p53 gene mutation in relation to p53 protein accumulation in male and female breast cancer. Neoplasma 1996;43:305-10.
92. Isola J, Visakorpi T, Holli K, Kallioniemi O-P. Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative cancer patients. J Natl Cancer Inst 1992;84:1109-14.
93. Anelli A, Anelli TFM, Youngson B, et al. Mutations of the p53 gene in male breast cancer. Cancer 1995;75:2233-8.
94. Dawson PJ, Schroer KR, Wolman SR. ras and p53 genes in male breast cancer. Mod Pathol 1996;9:367-70.
95. Hecht JR, Wong JT, Ramos L, et al. Male breast cancers rarely overexpress p53 protein (Abstr). Proc Am Assoc Cancer Res 1994;35:214.
96. Slamon DJ, Clark GM, Wong SG, et al. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987;235:177-82.
97. Slamon DJ, Godolphin W, Jones LA, et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989;244:707-12.
98. Blin N, Kardas I, Welter C, et al. Expression of the c-erbB-2 proto-oncogene in male breast carcinoma: Lack of prognostic sig-nificance. Oncology 1993;50:408-11.
99. Fox SB, Day CA, Rogers S. Lack of c-erbB-2 oncoprotein expression in male breast carcinoma. J Clin Pathol 1991;44:960-1.
100. Natali PG, Nicotra MR, Bigotti A. et al. Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissues. Int J Cancer 1990;45:457-61.
101. Dawson PJ, Paine TM, Wolman SR. Immunocytochemical characterization of male breast cancer. Mod Pathol 1992;5:621-5.
102. Wolman SR, Feiner HD, Schinella RA, et al. A retrospective analysis of breast cancer based on outcome differences. Hum Pathol 1991;22:475-80.